Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Synthetic Anti-infective Drugs >  Fosravuconazole L-lysine ethanolate

Fosravuconazole L-lysine ethanolate

Basic information Safety Supplier Related

Fosravuconazole L-lysine ethanolate Basic information

Product Name:
Fosravuconazole L-lysine ethanolate
Synonyms:
  • L-Lysine, coMpd. with 4-[2-[(1R,2R)-2-(2,4-difluorophenyl)-1-Methyl-2-[(phosphonooxy)Methoxy]-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile and ethanol (1:1:1) (9CI)
  • Fosravuconazole L-lysine ethanolate
  • BMS-379224 L-lysine ethanolate
  • E-1224 L-lysine ethanolate
  • Fungal,onychomycosis,Fosravuconazole Llysine ethanolate,Parasite,parasitemia,inhibit,Fosravuconazole L lysine ethanolate,antifungal,Ravuconazole,Inhibitor,candidiasis,Fosravuconazole L-lysine
  • (S)-2,6-Diaminohexanoic acid (((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl dihydrogen phosphate and ethanol salt
CAS:
914361-45-8
MF:
C31H40F2N7O8PS
MW:
739.73
Product Categories:
  • API
Mol File:
914361-45-8.mol
More
Less

Fosravuconazole L-lysine ethanolate Chemical Properties

storage temp. 
Store at -20°C
solubility 
DMSO : 50 mg/mL (67.59 mM; Need ultrasonic)| (insoluble)
form 
Solid
color 
White to yellow
Water Solubility 
Water : < 0.1 mg/mL (ultrasonic)
More
Less

Fosravuconazole L-lysine ethanolate Usage And Synthesis

Biological Activity

Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate), a prodrug of Ravuconazole, is an orally active broad-spectrum antifungal agent. Fosravuconazole L-lysine ethanolate can be used in the study of candidiasis, onychomycosis and parasitic diseases.

in vitro

Fosravuconazole has potent in vitro antifungal activity against a wide range of fungal species, including Candida , Aspergillus , and Trichophyton species .

in vivo

Fosravuconazole (E-1224; 10-50 mg/kg; oral administration; daily; for 20 days) treatment suppresses the parasitemia and prevents death in mice infected with the T. cruzi Y strain.

Animal Model: Swiss female mice (20-24 g) inoculated with trypomastigotes (Y strain).
Dosage: 10 mg/kg, 20 mg/kg, 30 mg/kg, 40 mg/kg , 50 mg/kg
Administration: Oral administration; daily; for 20 days
Result: Suppressed the parasitemia and prevented death.

Fosravuconazole L-lysine ethanolateSupplier

Shanghai Fuhe Chemistry Technology Co., Ltd.
Tel
0086-21-67651709
Email
cfx759@hotmail.com
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Shanghai eliv pharmaceutical Co.,Ltd.
Tel
021-50158063
Email
sales@elivpharma.com
Shanghai Rechem science Co., Ltd.
Tel
21-31433387 15618786686
Email
sales@rechemscience.com
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Email
Sales@ATKchemical.com